|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 260.30 EUR | +0.23% |
|
-1.88% | +5.30% |
| 01-14 | Sartorius Secures ISCC Plus Certification to Expand Bio-based Product Offering | MT |
| 01-14 | Sartorius Expands Bio-Circular Product Offering for More Sustainable Bioprocesses | CI |
| Capitalization | 15.91B 18.45B 14.81B 13.79B 25.67B 1,674B 27.62B 170B 67.16B 799B 69.19B 67.77B 2,916B | P/E ratio 2025 * |
91.6x | P/E ratio 2026 * | 64.5x |
|---|---|---|---|---|---|
| Enterprise value | 19.56B 22.69B 18.21B 16.95B 31.57B 2,059B 33.96B 209B 82.61B 982B 85.1B 83.35B 3,586B | EV / Sales 2025 * |
5.52x | EV / Sales 2026 * | 5.08x |
| Free-Float |
35.68% | Yield 2025 * |
0.28% | Yield 2026 * | 0.34% |
Last Transcript: Sartorius AG
| 1 day | +0.23% | ||
| 1 week | -1.88% | ||
| Current month | +5.30% | ||
| 1 month | +7.74% | ||
| 3 months | +22.61% | ||
| 6 months | +23.36% | ||
| Current year | +5.30% |
| 1 week | 251 | 266.5 | |
| 1 month | 233.3 | 267.7 | |
| Current year | 244.4 | 267.7 | |
| 1 year | 166.05 | 292 | |
| 3 years | 166.05 | 471.7 | |
| 5 years | 166.05 | 631.6 | |
| 10 years | 49.58 | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 30/06/2025 |
Florian Funck
DFI | Director of Finance/CFO | 54 | 01/04/2024 |
Volker Niebel
COO | Chief Operating Officer | 69 | 01/01/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 01/09/2002 |
Lothar Kappich
CHM | Chairman | 68 | 09/07/2017 |
Petra Kirchhoff
BRD | Director/Board Member | 57 | 01/10/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.23% | -1.88% | +10.30% | -37.34% | 18.4B | ||
| -2.55% | +1.13% | +151.14% | +166.07% | 3.18B | ||
| -6.16% | -0.93% | -17.56% | -60.75% | 2.4B | ||
| +1.30% | +6.29% | +4.87% | -4.77% | 1.17B | ||
| -1.25% | +0.06% | +17.99% | -43.94% | 923M | ||
| -1.66% | -2.79% | +13.03% | -39.01% | 917M | ||
| -1.35% | -3.08% | -18.46% | -41.36% | 689M | ||
| -0.51% | +4.15% | +1.77% | -33.38% | 581M | ||
| -1.62% | -7.62% | +158.09% | - | 419M | ||
| Average | -1.51% | -0.10% | +35.69% | -11.81% | 3.19B | |
| Weighted average by Cap. | -0.76% | -0.91% | +24.98% | -15.38% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.54B 4.11B 3.3B 3.07B 5.72B 373B 6.15B 37.94B 14.96B 178B 15.41B 15.1B 650B | 3.8B 4.41B 3.54B 3.29B 6.13B 400B 6.6B 40.69B 16.04B 191B 16.53B 16.19B 697B |
| Net income | 193M 224M 180M 167M 312M 20.33B 335M 2.07B 816M 9.7B 840M 823M 35.41B | 274M 318M 255M 237M 442M 28.82B 475M 2.93B 1.16B 13.75B 1.19B 1.17B 50.2B |
| Net Debt | 3.66B 4.24B 3.4B 3.17B 5.9B 385B 6.35B 39.16B 15.44B 184B 15.91B 15.58B 670B | 3.39B 3.93B 3.16B 2.94B 5.47B 357B 5.89B 36.31B 14.32B 170B 14.75B 14.45B 622B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 260.30 € | +0.23% | 73,391 |
| 15/01/26 | 259.70 € | +2.97% | 67,976 |
| 14/01/26 | 252.20 € | -2.89% | 82,720 |
| 13/01/26 | 259.70 € | -0.19% | 59,165 |
| 12/01/26 | 260.20 € | +1.13% | 60,748 |
Delayed Quote Xetra, January 16, 2026 at 07:35 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















